ARIPIPRAZOLE TABLETS — Class II drug recall D-0112-2021
Terminated recall by Golden State Medical Supply Inc., reported 2020-12-09, distributed nationwide. FAILED DISSOLUTION SPECIFICATIONS: Possibility of out-of-specification (OOS) dissolution limits for the remain
| Recall number | D-0112-2021 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Golden State Medical Supply Inc., Camarillo, CA, United States |
| Recall initiated | 2020-11-17 |
| Classified | 2020-11-30 |
| Reported by FDA | 2020-12-09 |
| Terminated | 2022-07-22 |
| Distributed | Nationwide (US) |
| Quantity | 11,922 bottles |
| Reason classes | specification failure |
| NDC | 60429-0449-30 |
| Lot numbers | GS026353, GS027150, GS027653, GS028044 |
| Expiration dates | 2021-02 |
Product
ARIPIPRAZOLE TABLETS, 15 mg, 30-count. bottles, Rx Only, GSMS Incorporated, Manufactured by: Apotex Inc. Toronto, Ontario, Canada, Packaged by GSMS, Incorporated, Camarillo, CA 93012 USA, NDC #60429-449-30
Reason for recall
FAILED DISSOLUTION SPECIFICATIONS: Possibility of out-of-specification (OOS) dissolution limits for the remaining shelf life of the Aripiprazole Tablets
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0112-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.